John Brendese
Rheumatology · Charlotte, NCNPI 1407841901
Payments from drug & device makers
Across 677 payments — averaging $177.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$100K
- Amgen$6K
- Janssen Research & Development, LLC$4K
- Sobi, Inc$2K
- Novartis$1K
- AbbVie$1K
- plus $6K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 94 | $99,666 |
| Amgen(2 entities) | 197 | $6,289 |
| Janssen Research & Development, LLC | 2 | $3,992 |
| Sobi, Inc | 4 | $2,253 |
| Novartis | 49 | $1,197 |
| AbbVie | 47 | $1,154 |
| UCB, Inc. | 48 | $1,030 |
| GSK | 55 | $1,015 |
| Johnson & Johnson | 34 | $879 |
| Lilly USA, LLC | 45 | $810 |
| E.r. Squibb & Sons, L.L.C. | 19 | $354 |
| AstraZeneca | 15 | $273 |
| Regeneron Healthcare Solutions, Inc. | 10 | $187 |
| Genentech USA, Inc. | 7 | $135 |
| Sanofi | 6 | $130 |
| Fresenius Kabi USA, LLC | 4 | $101 |
| Mallinckrodt Hospital Products Inc. | 4 | $87 |
| Organon | 3 | $64 |
| Boehringer Ingelheim | 3 | $62 |
| Radius Health, Inc. | 3 | $57 |
| Almatica Pharma LLC | 2 | $52 |
| Merck | 3 | $51 |
| Mallinckrodt Enterprises LLC | 2 | $50 |
| Bristol Myers Squibb | 1 | $45 |
| Janssen Scientific Affairs, LLC | 2 | $44 |
| Sandoz | 2 | $43 |
| Antares Pharma, Inc. | 2 | $33 |
| Aurinia Pharma U.S., Inc. | 2 | $33 |
| Zimmer Biomet | 1 | $23 |
| Tersera Therapeutics LLC | 1 | $23 |
| Assertio Therapeutics, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Medexus Pharma, Inc. | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $11 |
How this compares
$120,303 in reported general payments places this provider in the 80th percentile of 210 rheumatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Charlotte
- Jane BoxCharlotte$3.9M
- Gordon LamCharlotte$3.5M
- Alireza NamiCharlotte$3.1M
- Jill ZouzoulasCharlotte$440K
- Andrew LasterCharlotte$421K
- Leslie RankenCharlotte$207K
- Heather GladueCharlotte$168K
- Charles WithersCharlotte$149K
- Firas KassabCharlotte$80K
- Diane GeorgeCharlotte$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.